Article Information
PubMed
Print ISSN
Online ISSN
History
- Received July 22, 2003
- Accepted October 23, 2003
- Published online January 27, 2004.
Article Versions
- Earlier version (October 30, 2003 - 14:42).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Edward F. Nemeth,
- William H. Heaton,
- Michael Miller,
- John Fox,
- Manuel F. Balandrin,
- Bradford C. Van Wagenen,
- Mathew Colloton,
- William Karbon,
- Jon Scherrer,
- Edward Shatzen,
- Gilbert Rishton,
- Sheila Scully,
- Meiying Qi,
- Robert Harris,
- David Lacey and
- David Martin
- Departments of Metabolic Disorders (M.C., W.K., J.S., E.S., D.L., D.M.), Medicinal Chemistry (G.R.), Pathology (S.S., M.Q.), and Pharmacokinetics (R.H.), Amgen Inc., Thousand Oaks, California; and NPS Pharmaceuticals, Inc. (E.F.N., W.H.H., M.M., J.F., M.F.B., B.C.V.W.), Salt Lake City, Utah
- Address correspondence to:
Dr. David Martin, Department of Metabolic Disorders, MS 15-2-A, Amgen, Inc., One Amgen Center Dr., Thousand Oaks, CA 91320-1799. E-mail: dmartin{at}amgen.com